Selective Liver Estrogen Receptor α Modulation Prevents Steatosis, Diabetes, and Obesity Through the Anorectic Growth Differentiation Factor 15 Hepatokine in Mice-Reference-Cited by-同舟云学术

Selective Liver Estrogen Receptor α Modulation Prevents Steatosis, Diabetes, and Obesity Through the Anorectic Growth Differentiation Factor 15 Hepatokine in Mice

Published:2019-04-29 Issue:7 Volume:3 Page:908-924
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Guillaume Maeva¹²,Riant Elodie¹,Fabre Aurélie¹,Raymond‐Letron Isabelle³,Buscato Melissa¹,Davezac Morgane¹,Tramunt Blandine¹,Montagner Alexandra¹,Smati Sarra¹⁴,Zahreddine Rana¹,Palierne Gaëlle⁵,Valera Marie‐Cécile¹,Guillou Hervé⁴,Lenfant Françoise¹,Unsicker Klaus⁶,Metivier Raphaël⁵,Fontaine Coralie¹,Arnal Jean‐François¹,Gourdy Pierre¹⁷

Affiliation:

1. Institut des Maladies Métaboliques et Cardiovasculaires Unité Médicale de Recherche 1048, Institut National de la Santé et de le Recherche Médicale (INSERM), Université de Toulouse III Toulouse France

2. Service d’Hépato‐gastro‐entérologie Centre Hospitalier Universitaire de Toulouse Toulouse France

3. STROMALab, Centre National de la Recherche Scientifique ERL5311 Etablissement Français du Sang, Ecole Nationale Vétérinaire de Toulouse, Institut National de la Santé et de le Recherche Médicale (INSERM) U1031, Université de Toulouse III Toulouse France

4. Institut National de La Recherche Agronomique Unité Médicale de Recherche 1331, ToxAlim, Université de Toulouse Toulouse France

5. Equipe SP@RTE, Unité Médicale de Recherche 6290, Institut de Genétique et Développement de Rennes Université de Rennes 1 Rennes France

6. Institute of Anatomy and Cell Biology, Department of Molecular Embryology University of Freiburg Freiburg Germany

7. Service de Diabétologie Maladies Métaboliques et Nutrition, Centre Hospitalier Universitaire de Toulouse Toulouse France

Funder

Agence Nationale de la Recherche

Université de Toulouse

Fondation pour la Recherche Médicale

Fondation de France

Centre National de la Recherche Scientifique

Institut National de la Santé et de la Recherche Médicale

Société Francophone du Diabète

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1363

Reference44 articles.

1. Impaired estrogen receptor action in the pathogenesis of the metabolic syndrome

2. Towards optimization of estrogen receptor modulation in medicine

3. Hepatic estrogen receptor α improves hepatosteatosis through upregulation of small heterodimer partner

4. Estrogen Treatment After Ovariectomy Protects Against Fatty Liver and May Improve Pathway-Selective Insulin Resistance

5. Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic immune regulation and sex disparities;Nature Reviews Gastroenterology & Hepatology;2024-09-05

2. GDF15 is dispensable for the insulin-sensitizing effects of chronic exercise;Cell Reports;2024-08

3. Implications of innate immune sexual dimorphism for MASLD pathogenesis and treatment;Trends in Pharmacological Sciences;2024-07

4. Tamoxifen upregulates the peroxisomal β-oxidation enzyme Enoyl CoA hydratase and 3-hydroxyacyl CoA hydratase ameliorating hepatic lipid accumulation in mice;The International Journal of Biochemistry & Cell Biology;2024-07

5. Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease;Trends in Molecular Medicine;2024-06